Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review

Fig. 2

Reproduced from Curr Probl Cardiol. 2023;48(3), Kim JA, Wu L, Rodriguez M, et al. Recent developments in the evaluation and management of cardiorenal syndrome: a comprehensive review, page 101,509

Classification of CRS [51]. AKI Acute kidney injury, AMI Acute myocardial infarction, ATN acute tubular necrosis, CIN contrast-induced nephropathy, CKD chronic kidney disease, CM cardiomyopathy, COVID-19 coronavirus disease 2019, CRS cardiorenal syndrome, CS cardiogenic shock, HF heart failure, RAAS renin–angiotensin–aldosterone system, SLE systemic lupus erythematosus, SNS sympathetic nervous system.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840